These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 570847)

  • 21. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital deficiency of thromboxane and prostacyclin.
    Pareti FI; Mannucci PM; D'Angelo A; Smith JB; Sautebin L; Galli G
    Lancet; 1980 Apr; 1(8174):898-901. PubMed ID: 6103258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protein binding of thromboxane--one of the sources of error in thromboxane determination].
    Wirthumer-Hoche C; Sinzinger H
    Wien Klin Wochenschr; 1985 Mar; 97(6):282-5. PubMed ID: 3993037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder.
    Dubé JN; Drouin J; Aminian M; Plant MH; Laneuville O
    Br J Haematol; 2001 Jun; 113(4):878-85. PubMed ID: 11442478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis.
    Hook BG; Schumacher WA; Lee DL; Jolly SR; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(1):174-81. PubMed ID: 2580139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral heartache -- do platelets have a role?
    Handin RI; Alexander RW
    N Engl J Med; 1981 Apr; 304(17):1035-6. PubMed ID: 7010170
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds.
    Gerrard JM; Singhroy S; Duta E; Nosek-Cenkowska B; Israels SJ; Israels ED
    Thromb Res; 1990 Oct; 60(1):79-85. PubMed ID: 2278038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired platelet thromboxane production in renal failure.
    Smith MC; Dunn MJ
    Nephron; 1981; 29(3-4):133-7. PubMed ID: 7329487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man.
    Eldor A; Zylber-Katz E; Levy M
    Eur J Clin Pharmacol; 1984; 26(2):171-6. PubMed ID: 6723755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro.
    Hirakata H; Nakamura K; Yokubol B; Toda H; Hatano Y; Urabe N; Mori K
    Anesthesiology; 1999 Nov; 91(5):1361-9. PubMed ID: 10551587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of thromboxane A2 as a mediator of platelet-activating-factor-induced aggregation of human platelets.
    McCulloch RK; Summers J; Vandongen R; Rouse IL
    Clin Sci (Lond); 1989 Jul; 77(1):99-103. PubMed ID: 2758765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD; Seuter F
    Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.